Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer

NCT03951389 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

NCT NCT03951389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03951389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INST 1204: PIK3CA Mutations as Biomarkers for Metastasis in Colon Cancer
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Observational
Overall status
Completed
Start date
May 22, 2012
Completion date
October 21, 2019
Enrollment
750 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer